STOCK TITAN

Mainz Biomed NV Stock Price, News & Analysis

QUCY Nasdaq

Welcome to our dedicated page for Mainz Biomed NV news (Ticker: QUCY), a resource for investors and traders seeking the latest updates and insights on Mainz Biomed NV stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Mainz Biomed NV's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Mainz Biomed NV's position in the market.

Rhea-AI Summary

Quantum Cyber (NASDAQ: QUCY) said it is aligning strategy with the Trump Administration’s National Cybersecurity Strategy and is evaluating strategic acquisitions in quantum computing, post-quantum cryptography, and zero-trust network architecture. The company disclosed that lead shareholder David Lazar pre-funded a second tranche of $3.0 million, bringing his total commitment to $6.0 million. The company said no definitive acquisition agreements have been reached and share issuance remains subject to customary closing conditions and shareholder approval.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-17.75%
Tags
none
-
Rhea-AI Summary

Quantum Cyber (NASDAQ: QUCY) announced it changed its Nasdaq ticker to QUCY effective March 12, 2026, and plans a corporate name change to Quantum Cyber N.V. subject to a shareholder meeting planned for April 2026.

The company said the rebranding and ticker update align with a strategic shift toward quantum computing and cybersecurity offerings as it transitions from its prior identity.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.77%
Tags
none

FAQ

What is the current stock price of Mainz Biomed NV (QUCY)?

The current stock price of Mainz Biomed NV (QUCY) is $0.5689 as of March 17, 2026.

What is the market cap of Mainz Biomed NV (QUCY)?

The market cap of Mainz Biomed NV (QUCY) is approximately 8.7M.

QUCY Rankings

QUCY Stock Data

8.66M
7.48M
Diagnostics & Research
Healthcare
Link
Germany
Mainz

QUCY RSS Feed